Do not throw that pomegranate peel in the garbage bin. In the near future, it may be a source of drugs for two incurable diseases that affect the elderly.
Two years of research by a Nigerian scientist has shown that sufferers of Alzheimer's and Parkinson's disease could be helped by punicalagin, a compound extracted from pomegranates.
Olumayokun Olajide from the University of Huddersfield in West Yorkshire showed how punicalagin could inhibit inflammation in specialised brain cells known as micrologia.
He also found the painful inflammation that accompanies illnesses such as rheumatoid arthritis and Parkinson's disease could be reduced using the same drug.
"We do know that regular consumption of pomegranate has a lot of health benefits, including prevention of neuro-inflammation related to dementia," Olajide added.
He recommended juice products that have real pomegranate that will have nearly 3.4 percent of the wonder compound punicalagin.
"Most of the anti-oxidant compounds are found in the outer skin of the pomegranate and not in the soft part of the fruit," Olajide added.
Alzheimer's has no cure and sufferers get progressively worse but the new compound could prevent it or slow down its development, he said.
The research was published in the journal Molecular Nutrition and Food Research.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
